Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 37% ± 14% | |
hematopoietic precursor cell | 4 studies | 26% ± 9% | |
conventional dendritic cell | 4 studies | 29% ± 12% | |
endothelial cell | 4 studies | 23% ± 10% | |
ciliated cell | 4 studies | 22% ± 6% | |
basal cell | 4 studies | 25% ± 11% | |
plasmablast | 3 studies | 43% ± 11% | |
classical monocyte | 3 studies | 20% ± 6% | |
non-classical monocyte | 3 studies | 23% ± 4% | |
kidney loop of Henle epithelial cell | 3 studies | 25% ± 4% | |
retinal cone cell | 3 studies | 43% ± 15% | |
fibroblast | 3 studies | 24% ± 8% | |
endothelial cell of lymphatic vessel | 3 studies | 22% ± 6% | |
erythroblast | 3 studies | 29% ± 8% | |
macrophage | 3 studies | 25% ± 3% | |
dendritic cell | 3 studies | 40% ± 1% | |
intestinal crypt stem cell | 3 studies | 25% ± 3% | |
natural killer cell | 3 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of MRPL15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1450.00 | 226 / 226 | 100% | 92.72 | 406 / 406 |
ovary | 100% | 972.69 | 180 / 180 | 100% | 131.45 | 430 / 430 |
esophagus | 100% | 1480.02 | 1444 / 1445 | 100% | 72.89 | 183 / 183 |
intestine | 100% | 1700.83 | 966 / 966 | 100% | 121.60 | 526 / 527 |
uterus | 100% | 979.71 | 170 / 170 | 100% | 105.03 | 458 / 459 |
stomach | 100% | 1278.10 | 358 / 359 | 100% | 108.83 | 286 / 286 |
skin | 100% | 2107.98 | 1809 / 1809 | 100% | 123.26 | 470 / 472 |
kidney | 100% | 2084.22 | 89 / 89 | 100% | 84.21 | 897 / 901 |
breast | 100% | 1406.68 | 458 / 459 | 100% | 107.78 | 1114 / 1118 |
bladder | 100% | 1428.48 | 21 / 21 | 99% | 124.78 | 501 / 504 |
brain | 99% | 1337.77 | 2614 / 2642 | 100% | 81.92 | 705 / 705 |
prostate | 99% | 926.30 | 243 / 245 | 99% | 76.24 | 498 / 502 |
thymus | 100% | 1150.79 | 650 / 653 | 99% | 54.64 | 598 / 605 |
adrenal gland | 100% | 1530.46 | 258 / 258 | 97% | 60.83 | 223 / 230 |
pancreas | 96% | 712.33 | 316 / 328 | 99% | 71.86 | 177 / 178 |
lung | 95% | 1028.66 | 547 / 578 | 100% | 98.54 | 1155 / 1155 |
adipose | 100% | 1512.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 130.67 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 100.48 | 29 / 29 |
muscle | 100% | 4450.12 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1257.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 86.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.46 | 1 / 1 |
blood vessel | 99% | 931.55 | 1316 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 3153.49 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 892.71 | 571 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0032543 | Biological process | mitochondrial translation |
GO_0005762 | Cellular component | mitochondrial large ribosomal subunit |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | MRPL15 |
Protein name | Large ribosomal subunit protein uL15m (39S ribosomal protein L15, mitochondrial) Large ribosomal subunit protein uL15m (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15) |
Synonyms | HSPC145 |
Description | |
Accessions | E5RIZ4 ENST00000260102.9 ENST00000519831.5 Q9P015 ENST00000522521.2 E5RHF4 |